-
1101
-
1102
-
1103
-
1104
-
1105
Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis
Published 2018-01-01Get full text
Article -
1106
-
1107
-
1108
-
1109
-
1110
Occurrence and assessment of chronic pain fatigue and sleep disturbance in axial spondyloarthritis patients
Published 2025-12-01Get full text
Article -
1111
Clinical Characteristics and Treatment Options of Peripheral Spondyloarthritis
Published 2024-12-01Get full text
Article -
1112
-
1113
Tophaceous Gout and Renal Insufficiency: A New Solution for an Old Therapeutic Dilemma
Published 2011-01-01Get full text
Article -
1114
-
1115
A Mechanistic Insight into the Pathogenic Role of Interleukin 17A in Systemic Autoimmune Diseases
Published 2022-01-01Get full text
Article -
1116
A Young Male with Severe Myocarditis and Skeletal Muscle Myositis
Published 2018-01-01“…The patient is undergoing regular follow-up in both cardiology and rheumatology outpatient departments. Repeated MRI of the legs showed significant interval improvement in his skeletal muscle myositis, and repeat cardiac MRI demonstrated the resolution of myocarditis along with persistent stable extensive myocardial fibrosis and preserved LVEF. …”
Get full text
Article -
1117
Erratum to “Ferritin in Adult-Onset Still’s Disease: Just a Useful Innocent Bystander?”
Published 2012-01-01Get full text
Article -
1118
Work loss in patients with rheumatoid arthritis treated with abatacept, rituximab, tocilizumab or TNF inhibitors: a nationwide direct drug-to-drug comparison
Published 2025-01-01“…Objective To compare work loss after starting tumour necrosis factor inhibitors (TNFi), rituximab, abatacept or tocilizumab in patients with rheumatoid arthritis (RA).Methods We used data from the Swedish Rheumatology Quality Register to identify patients aged 19-62 years who were treated with TNFi (n=15 093), rituximab (n=2123), abatacept (n=1877) or tocilizumab (n=1720) between 2007 and 2020. …”
Get full text
Article -
1119
-
1120